Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Adriaan Kooy"'
Autor:
Erwin Birnie, Giesje Nefs, Bruce H R Wolffenbuttel, Melanie M van der Klauw, Peter R van Dijk, Klaas Hoogenberg, Henk J Veeze, Henk-Jan Aanstoot, Bruce HR Wolffenbuttel, Charlotte E Vollenbrock, Pim Dekker, Lianne S M Boesten, Martine M C de Vries-Velraeds, Adriaan Kooy, Dick Mul, Sanjoy Dutta, Rita D M Varkevisser, Michael P Brugts, Petronella H L M Duijvestijn, Christine Fransman, Rob K Gonera, Esther Latres, Sandra Loves, Theo Sas, Marleen J Vosjan-Noeverman, Rita DM Varkevisser, Lianne SM Boesten, Petronella HLM Duijvestijn, Martine MC de Vries-Velraeds
Publikováno v:
BMJ Open, Vol 14, Iss 6 (2024)
Purpose The ‘Biomarkers of heterogeneity in type 1 diabetes’ study cohort was set up to identify genetic, physiological and psychosocial factors explaining the observed heterogeneity in disease progression and the development of complications in
Externí odkaz:
https://doaj.org/article/4a35451d61fd41a4ac200f129136139b
Autor:
Johanna M. G. Stultiens, Wiebe M. C. Top, Dorien M. Kimenai, Philippe Lehert, Otto Bekers, Coen D. A. Stehouwer, Adriaan Kooy, Steven J. R. Meex
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-10 (2022)
Abstract Background Metformin has favorable effects on cardiovascular outcomes in both newly onset and advanced type 2 diabetes, as previously reported findings from the UK Prospective Diabetes Study and the HOME trial have demonstrated. Patients wit
Externí odkaz:
https://doaj.org/article/808d5801eeec4e9d8ff969abbd95cf78
Autor:
Peter R van Dijk, Klaas Hoogenberg, Jelmer R Prins, Jan Jaap H M Erwich, Adriaan Kooy, Eline G M van Hoorn, Helen L Lutgers
Publikováno v:
BMJ Open, Vol 12, Iss 3 (2022)
Introduction Gestational diabetes mellitus (GDM) is a common disorder of pregnancy with health risks for mother and child during pregnancy, delivery and further lifetime, possibly leading to type 2 diabetes mellitus (T2DM). Current treatment is focus
Externí odkaz:
https://doaj.org/article/ff0bcca4e8864ce985b117124f8fea64
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0247939 (2021)
BackgroundBeyond antihyperglycemic effects, metformin may improve cardiovascular outcomes. Patients with type 2 diabetes often have an elevated plasma level of N-terminal pro B-type as a marker of (sub) clinical cardiovascular disease. We studied whe
Externí odkaz:
https://doaj.org/article/b3de305a3c704f6c9ec850ac7ca1e5df
Publikováno v:
Pharmaceuticals, Vol 15, Iss 3, p 312 (2022)
The biguanide metformin has been used as first-line therapy in type 2 diabetes mellitus (T2DM) treatment for several decades. In addition to its glucose-lowering properties and its prevention of weight gain, the landmark UK Prospective Diabetes Study
Externí odkaz:
https://doaj.org/article/faeb4f58ed874f40a1ca70c9aa8aa9dc
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity. 16:1383-1391
Ben Imholz,1 Jack Heijster,1 Abd Tahrani,2 Adriaan Kooy3 1Department of Internal Medicine, ETZ Ziekenhuis, Tilburg, the Netherlands; 2Department of Endocrinology and Diabetes, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; 3Dep
Autor:
Viktor Rotbain Curovic, Niels Jongs, Marjolein Y.A.M. Kroonen, Emilie H. Zobel, Tine W. Hansen, Taha Sen, Gozewijn D. Laverman, Adriaan Kooy, Frederik Persson, Peter Rossing, Hiddo J.L. Heerspink
Publikováno v:
Diabetes Care. 46:593-601
OBJECTIVERenin–angiotensin system (RAS) inhibitors decrease the urinary albumin to creatinine ratio (UACR) but are ineffective in up to 40% of patients. We hypothesized that rotation through different drug classes overcomes RAS inhibitor resistance
Autor:
Taha Sen, Viktor Rotbain Curovic, Niels Jongs, Gozewijn D. Laverman, Adriaan Kooy, Frederik Persson, Peter Rossing, Hiddo J. L. Heerspink
Publikováno v:
Diabetes, Obesity and Metabolism.
Autor:
null Taha Sen, null Viktor Rotbain Curovic, null Niels Jongs, null Gozewijn D. Laverman, null Adriaan Kooy, null Frederik Persson, null Peter Rossing, null Hiddo J. L. Heerspink
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d03de905a9d10eaa19a5c9171541662f
https://doi.org/10.1111/dom.15109/v2/response1
https://doi.org/10.1111/dom.15109/v2/response1
Autor:
Viktor Curovic, Nete Tofte, Morten Lindhardt, Katarina Adamova, Stephan J.L. Bakker, Joachim Beige, Joline W.J. Beulens, Andreas L. Birkenfeld, Gemma Currie, Christian Delles, Ingo Dimos, Lidmila Francová, Marie Frimodt-Møller, Peter Girman, Rüdiger Göke, Tine W. Hansen, Tereza Havrdova, Adriaan Kooy, Gozewijnw D. Laverman, Harald Mischak, Gerjan Navis, Giel Nijpels, Marina Noutsou, Alberto Ortiz, Aneliya Parvanova, Frederik Persson, John R. Petrie, Piero L. Ruggenenti, Femke Rutters, Ivan Rychlík, Justyna Siwy, Goce Spasovski, Marijn Speeckaert, Matias Trillini, Petra Zürbig, Heiko von der Leyen, Peter Rossing
Publikováno v:
on the behalf of the PRIORITY Study Group 2023, ' Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria – A post-hoc analysis of the PRIORITY randomized clinical trial ', Journal of Diabetes and its Complications, vol. 37, no. 4, 108433 . https://doi.org/10.1016/j.jdiacomp.2023.108433
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 37(4):108433. ELSEVIER SCIENCE INC
Journal of Diabetes and its Complications, 37(4):108433. Elsevier Inc.
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 37(4):108433. ELSEVIER SCIENCE INC
Journal of Diabetes and its Complications, 37(4):108433. Elsevier Inc.
Background Diabetic retinopathy (DR) is a microvascular complication of diabetes highly associated to cardiovascular disease and diabetic kidney disease. However, these associations are not thoroughly investigated at an early type 2 diabetes disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e6c41519a1fa5a3ed2e9cad5493c814
https://research.vumc.nl/en/publications/4d70eb09-8ee3-4312-8a47-f3b7f1402222
https://research.vumc.nl/en/publications/4d70eb09-8ee3-4312-8a47-f3b7f1402222